Imatinib
targeted anticancer therapy · kinase inhibitor
Nothing to addWhat this medicine is for
Imatinib belongs to the 'targeted anticancer therapy (kinase inhibitor)' category. This targeted therapy attacks a specific mechanism of the tumour cells; it comes under a specialised hospital prescription.
For Imatinib, in practice: Treats a cancer by targeting tumour cells. Its prescription and administration fall within a specialised, often hospital, setting.
Under which brands it is found
Imatinib is found in around 12 presentations listed in France. It is available under various brand names and as generics.
- Imatinib Accord
- Imatinib Arrow Lab
- Imatinib Bgr
- Imatinib Cristers
- Imatinib Eg
- Imatinib Eg Labo
- Imatinib Hcs
- Imatinib Sandoz
- and other presentations
Generics and the original brand are equivalent for the active substance; only the appearance, the name or the excipients may differ.
Do you need a supplement? No.
We put forward no supplement for Imatinib: that would be forcing a need that does not exist. The great majority of medicines call for no particular supplementation, and acknowledging this is part of the way we work. We design a supplement only where the data support it, across five specific classes.
Talk about it in the community
A space to share among people who are affected: the early days, the habits built up over the years, what each person has found to live better with it. Shared experiences, nothing medical.
Related molecules
To explore in the « Other areas » family and its neighbours.